Researchers want trustworthy, human-relevant models. Integrating automation and AI into organoid development workflows—or opting for validated off-the-shelf models—are a few innovative and accessible ...
Absci has built a leading generative AI Drug Creation platform for therapeutic antibodies and we’re excited to bring this expertise into animal health,” said Sean McClain, Founder and CEO of Absci.
The University of British Columbia Okanagan is introducing a Master of Biotechnology program that will prepare students to work in the biotechnology industry. The 16-month program combines coursework, ...
The global insect cell lines market is on a trajectory of unprecedented growth, projected to soar to USD 3 billion by 2033 from USD 1 billion in 2023, as reported by Future Market Insights (FMI). This ...